Compare ENGN & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENGN | TRAK |
|---|---|---|
| Founded | 1999 | 1990 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | EDP Services |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.2M | 125.2M |
| IPO Year | 2023 | 1996 |
| Metric | ENGN | TRAK |
|---|---|---|
| Price | $1.95 | $7.25 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $4.29 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 79.1K |
| Earning Date | 12-21-2026 | 11-16-2026 |
| Dividend Yield | N/A | ★ 1.09% |
| EPS Growth | ★ 56.85 | 11.43 |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | ★ $21,007,076.00 |
| Revenue This Year | N/A | $9.50 |
| Revenue Next Year | N/A | $10.00 |
| P/E Ratio | ★ N/A | $18.93 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $1.40 | $6.61 |
| 52 Week High | $12.25 | $14.55 |
| Indicator | ENGN | TRAK |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | 48.00 |
| Support Level | $1.61 | $6.89 |
| Resistance Level | $8.93 | $7.46 |
| Average True Range (ATR) | 0.18 | 0.37 |
| MACD | 0.07 | 0.06 |
| Stochastic Oscillator | 47.17 | 57.35 |
enGene Therapeutics Inc is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, to create new ways to address diseases with high clinical needs. Its pioneering program is detalimogene voraplasmid (also known as detalimogene) for patients with Non-Muscle Invasive Bladder Cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase 2 trial, which includes a pivotal cohort studying detalimogene in high-risk, Bacillus Calmette-Guerin (BCG)-unresponsive patients with carcinoma in situ (CIS) with or without concomitant papillary disease. It is developed using enGene's proprietary Dually Derivatized Oligochitosan (DDX) platform.
ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.